BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 38057686)

  • 1. Crown-like structures in breast adipose tissue of breast cancer patients: associations with CD68 expression, obesity, metabolic factors and prognosis.
    Chang MC; Eslami Z; Ennis M; Goodwin PJ
    NPJ Breast Cancer; 2021 Jul; 7(1):97. PubMed ID: 34294716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer treatment in mutation carriers: surgical treatment.
    Biglia N; D'Alonzo M; Sgro LG; Tomasi Cont N; Bounous V; Robba E
    Minerva Ginecol; 2016 Oct; 68(5):548-56. PubMed ID: 26822896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1/2 gene mutation carriers and breast cancer patients.
    Zwager MC; Holt-Kedde I; Timmer-Bosscha H; de Bock GH; Werker PMN; Schröder CP; van der Vegt B; Arjaans M
    Breast Cancer Res Treat; 2024 Feb; 204(1):27-37. PubMed ID: 38057686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
    Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
    Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer.
    Guzmán-Arocho YD; Rosenberg SM; Garber JE; Vardeh H; Poorvu PD; Ruddy KJ; Kirkner G; Snow C; Tamimi RM; Peppercorn J; Schapira L; Borges VF; Come SE; Brachtel EF; Marotti JD; Warner E; Partridge AH; Collins LC
    Br J Cancer; 2022 Feb; 126(2):302-309. PubMed ID: 34703009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of BRCA1 and BRCA2 Mutations Among High-risk Bahraini Patients with Breast Cancer.
    Bukamal Z; AlRayes A
    Gulf J Oncolog; 2023 May; 1(42):22-25. PubMed ID: 37283256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer.
    Sønderstrup IMH; Jensen MB; Ejlertsen B; Eriksen JO; Gerdes AM; Kruse TA; Larsen MJ; Thomassen M; Laenkholm AV
    Acta Oncol; 2019 Mar; 58(3):363-370. PubMed ID: 30614364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation and Dysregulation of Endothelial Permeability during Systemic Inflammation.
    Hellenthal KEM; Brabenec L; Wagner NM
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of crown-like structures to trastuzumab response in patients with primary invasive HER2 + breast carcinoma.
    Birts CN; Savva C; Laversin SA; Lefas A; Krishnan J; Schapira A; Ashton-Key M; Crispin M; Johnson PWM; Blaydes JP; Copson E; Cutress RI; Beers SA
    Sci Rep; 2022 May; 12(1):7802. PubMed ID: 35610242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? A Mini review.
    Daniele A; Divella R; Pilato B; Tommasi S; Pasanisi P; Patruno M; Digennaro M; Minoia C; Dellino M; Pisconti S; Casamassima P; Savino E; Paradiso AV
    Hered Cancer Clin Pract; 2021 Oct; 19(1):45. PubMed ID: 34706754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer.
    Mehta AK; Cheney EM; Hartl CA; Pantelidou C; Oliwa M; Castrillon JA; Lin JR; Hurst KE; de Oliveira Taveira M; Johnson NT; Oldham WM; Kalocsay M; Berberich MJ; Boswell SA; Kothari A; Johnson S; Dillon DA; Lipschitz M; Rodig S; Santagata S; Garber JE; Tung N; Yélamos J; Thaxton JE; Mittendorf EA; Sorger PK; Shapiro GI; Guerriero JL
    Nat Cancer; 2021 Jan; 2(1):66-82. PubMed ID: 33738458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White women with breast cancer.
    Maliniak ML; Cheriyan AM; Sherman ME; Liu Y; Gogineni K; Liu J; He J; Krishnamurti U; Miller-Kleinhenz J; Ashiqueali R; He J; Yacoub R; McCullough LE
    Breast Cancer Res; 2020 Jun; 22(1):65. PubMed ID: 32552729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ECM1 secreted by HER2-overexpressing breast cancer cells promotes formation of a vascular niche accelerating cancer cell migration and invasion.
    Steinhaeuser SS; Morera E; Budkova Z; Schepsky A; Wang Q; Rolfsson O; Riedel A; Krueger A; Hilmarsdottir B; Maelandsmo GM; Valdimarsdottir B; Sigurdardottir AK; Agnarsson BA; Jonasson JG; Ingthorsson S; Traustadottir GA; Oskarsson T; Gudjonsson T
    Lab Invest; 2020 Jul; 100(7):928-944. PubMed ID: 32203150
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.